These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36649046)

  • 1. Melatonin as a Repurposed Drug for Melanoma Treatment.
    Pathipaka R; Thyagarajan A; Sahu RP
    Med Sci (Basel); 2023 Jan; 11(1):. PubMed ID: 36649046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
    Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
    J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways.
    Yi C; Zhang Y; Yu Z; Xiao Y; Wang J; Qiu H; Yu W; Tang R; Yuan Y; Guo W; Deng W
    PLoS One; 2014; 9(7):e99943. PubMed ID: 25000190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice.
    Otálora BB; Madrid JA; Alvarez N; Vicente V; Rol MA
    J Pineal Res; 2008 Apr; 44(3):307-15. PubMed ID: 18339126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma.
    Lissoni P; Brivio O; Brivio F; Barni S; Tancini G; Crippa D; Meregalli S
    J Pineal Res; 1996 Nov; 21(4):239-42. PubMed ID: 8989723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin as a potential anticarcinogen for non-small-cell lung cancer.
    Ma Z; Yang Y; Fan C; Han J; Wang D; Di S; Hu W; Liu D; Li X; Reiter RJ; Yan X
    Oncotarget; 2016 Jul; 7(29):46768-46784. PubMed ID: 27102150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin.
    Sadoughi F; Maleki Dana P; Homayoonfal M; Sharifi M; Asemi Z
    Biochimie; 2022 Nov; 202():15-25. PubMed ID: 35636690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of melatonin on hamster melanoma.
    Ghosh BC; el-Domeiri AA; Das Gupta TK
    Surg Forum; 1973; 24():121-2. PubMed ID: 4805963
    [No Abstract]   [Full Text] [Related]  

  • 9. Melatonin-Induced Cytoskeleton Reorganization Leads to Inhibition of Melanoma Cancer Cell Proliferation.
    Alvarez-Artime A; Cernuda-Cernuda R; Francisco-Artime-Naveda ; Cepas V; Gonzalez-Menendez P; Fernadez-Vega S; Quiros-Gonzalez I; Sainz RM; Mayo JC
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure.
    Yerneni LK; Jayaraman S
    Melanoma Res; 2003 Apr; 13(2):113-7. PubMed ID: 12690293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells.
    Bilska B; Schedel F; Piotrowska A; Stefan J; Zmijewski M; Pyza E; Reiter RJ; Steinbrink K; Slominski AT; Tulic MK; Kleszczyński K
    J Pineal Res; 2021 Apr; 70(3):e12728. PubMed ID: 33650175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pineal ablation and administration of melatonin on growth and spread of hamster melanoma.
    El-Domeiri AA; Das Gupta TK
    J Surg Oncol; 1976; 8(3):197-205. PubMed ID: 933542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry of the pineal gland as an endocrine organ.
    Feuer G
    Drug Metabol Drug Interact; 1990; 8(3-4):203-46. PubMed ID: 2099891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin and mammary pathological growth.
    Cos S; Sánchez-Barceló EJ
    Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of melatonin in prevention and treatment of lung cancer.
    Ngai ZN; Chok KC; Ng KY; Koh RY; Chye SM
    Horm Mol Biol Clin Investig; 2022 Dec; 43(4):485-503. PubMed ID: 35728260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.
    Hagström A; Kal Omar R; Williams PA; Stålhammar G
    BMC Cancer; 2022 Apr; 22(1):398. PubMed ID: 35413810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatic effects of the pineal gland.
    Kerenyi NA; Pandula E; Feuer GM
    Drug Metabol Drug Interact; 1990; 8(3-4):313-9. PubMed ID: 2099893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
    Samanta S
    J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin in cancer management: progress and promise.
    Jung B; Ahmad N
    Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells.
    Kadekaro AL; Andrade LN; Floeter-Winter LM; Rollag MD; Virador V; Vieira W; Castrucci AM
    J Pineal Res; 2004 Apr; 36(3):204-11. PubMed ID: 15009512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.